Grady Chang


+1 310 883 6402

Grady Chang has represented issuers, private equity firms and investment banks on capital markets and corporate transactions, including initial public offerings, other equity offerings, high-yield and investment-grade offerings and acquisition financing. Grady also counsels public companies with respect to general corporate and securities matters, including SEC reporting obligations and corporate governance.

Download full bio


  • Canoo to List on Nasdaq Through Hennessy Capital Merger 

  • Hyliion to Combine With Tortoise, a Special Purpose Acquisition Company 

  • Avidity Biosciences - $289 Million IPO 

  • 89bio – $98 Million IPO 

  • Satsuma Pharmaceuticals – $83 Million IPO  


  • University of Chicago Law School
    JD, 2014

  • Duke University
    BA, 2010

Admissions & Credentials


New York


+1 310 883 6402 office

1333 2nd Street
Suite 400
Santa Monica, CA 90401